Assembly Biosciences Inc reports results for the quarter ended in January - Earnings Summary

Assembly Biosciences

09/08/2024 24:11

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of $2.05​​ per share for the quarter ended in January,
higher than the same quarter last year, when the company
reported EPS of $-3.84.  The lone analyst forecast for the
quarter was for a loss of $2.23 per share. 
    * Revenue was $8.53 million​; analysts expected $5.96
million. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of $1.98​.
    * The company reported a quarterly loss of $11.15 million.
    * Assembly Biosciences Inc shares had fallen by 8.0% this
quarter and gained 28.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Assembly
Biosciences Inc is $36.00 
This summary was machine generated from LSEG data August 8 at
11:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -2.23          -2.05          Beat
 Mar. 31 2024      -3.23          -1.66          Beat
 Dec. 31 2023      -2.88          -2.15          Beat
 Sep. 30 2023      -2.76          -3.24          Missed